Worth reading
72In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
2640000
Japanese yen (total issue price)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of the 19th Series Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause)
Who receives how much
Potential shares: 24,000,000 (240,000 stock acquisition rights, with each stock acquisition right representing 100 shares)
Name: EVO FUND; 240,000 stock acquisition rights
The lower thin line represents the existing number of shares to which these shares will be added.
¥11 per stock acquisition right
Total issue value
¥2,640,000
Amount of funds to be raised
¥1,331,640,000 (Note: The actual amount raised may fluctuate.)
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥56. From the second trading day after the allotment date, the exercise price will generally be adjusted to 100% of the closing price on the price calculation date. Minimum exercise price: ¥28. No maximum exercise price.
Exercise period
From 15 June 2026 to 15 March 2027
Number of Stock Acquisition Rights
Total issued: 240,000 stock acquisition rights. Outstanding unexercised rights: Not disclosed
Reason for acquisition without consideration
These are not subject to cost-free acquisition. If the Company resolves to acquire them or if they remain outstanding at the end of the exercise period, the Company will acquire them for an amount equal to the payment amount per stock acquisition right.
Payment date
12 June 2026
Most recent equity financing
Issuance of the 19th Series Stock Acquisition Rights through third-party allotment and the 2nd Series Unsecured Bonds (privately placed), as resolved on 27 May 2026 (referenced in this document)
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of the 19th Series Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Potential shares: 24,000,000 (240,000 stock acquisition rights, with each stock acquisition right representing 100 shares) |
| Issue price and disposal price | ¥11 per stock acquisition right |
| Total issue value | ¥2,640,000 |
| Amount of funds to be raised | ¥1,331,640,000 (Note: The actual amount raised may fluctuate.) |
| Payment date | 12 June 2026 |
| Intended allottee | Name: EVO FUND; 240,000 stock acquisition rights |
| Exercise price | Initial exercise price: ¥56. From the second trading day after the allotment date, the exercise price will generally be adjusted to 100% of the closing price on the price calculation date. Minimum exercise price: ¥28. No maximum exercise price. |
| Exercise period | From 15 June 2026 to 15 March 2027 |
| Number of Stock Acquisition Rights | Total issued: 240,000 stock acquisition rights. Outstanding unexercised rights: Not disclosed |
| Reason for acquisition without consideration | These are not subject to cost-free acquisition. If the Company resolves to acquire them or if they remain outstanding at the end of the exercise period, the Company will acquire them for an amount equal to the payment amount per stock acquisition right. |
| Most recent equity financing | Issuance of the 19th Series Stock Acquisition Rights through third-party allotment and the 2nd Series Unsecured Bonds (privately placed), as resolved on 27 May 2026 (referenced in this document) |
Items this document does not state (16)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price for the 19th Series Stock Acquisition Rights, whose issuance was resolved at the Board of Directors meeting held on 27 May 2026, was completed on 12 June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.